RESTON, Va. -- Leading molecular imaging and nuclear medicine authorities will address more than 4,000 physicians, technologists, scientists and pharmacists about future directions and the latest medical research results during SNM's 53rd Annual Meeting June 3-7 at the San Diego Convention Center.

"We know that molecular imaging and nuclear medicine will lead to a much greater ability to characterize diseases, diagnose them at a very early stage, treat them effectively and monitor the effectiveness of such treatment," said SNM President Peter S. Conti, M.D., Ph.D., who is professor of radiology, clinical pharmacy and biomedical engineering at the University of Southern California, Los Angeles, and director of the PET Imaging Science Center at USC's Keck School of Medicine. "Molecular imaging and nuclear medicine research have a proven record of leading to improvements in the diagnosis and treatment of life-threatening cancer, heart and other diseases that affect millions each year," noted Conti, speaking on behalf of the society, which has more than 16,000 physician, technologist and scientist members in 78 countries. "Medical practitioners, technologists, scientists, physicists and pharmacists from around the world come to this premier event for molecular imaging and nuclear medicine educational opportunities," he explained, adding, "This meeting brings together the best and brightest."

"SNM's Annual Meeting is the place for all practitioners of molecular imaging and nuclear medicine to find high-quality resources, education, products and services to help them meet the demands of this cutting-edge medical profession," noted SNM Technologist Section President Valerie R. Cronin, CNMT, FSNMTS, director of imaging services in the Catholic Health System of Western New York in Buffalo, N.Y. This year, SNM and the SNM Technologist Section will present about 100 continuing education courses focusing on molecular imaging in clinical practice, PET/CT, brain imaging, pediatrics, oncology and therapy, thyroid cancer, cardiovascular nuclear medicine, radiation safety, molecular and clinical brain imaging, she added. Typically, more than 1,600 scientific, technologist and technologist-student abstracts are presented featuring the latest research in the molecular imaging and nuclear medicine profession. This year, one session will provide a look at events in Chernobyl in the former USSR (now the Ukraine) on the 20th anniversary of that city's nuclear power accident.

More Industry Headlines